Who is sponsoring NCT04807465?

NCT04807465 is sponsored by Hacettepe University.

What drugs are being tested in NCT04807465?

Interventions in NCT04807465: G-Premio Bond in etch&rinse mode, G-Premio Bond in selective-etch mode, G-Premio Bond in self-etch mode.

What condition does NCT04807465 study?

NCT04807465 studies Healthy Participant.

Is NCT04807465 still recruiting?

NCT04807465 is currently status unknown. Last updated 23 March 2021.

Last reviewed 2021-03-23 · How we verify

NCT04807465

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Different Modes of Universal Adhesive in Smokers and Non-Smokers

Status unknown NA Last updated 23 March 2021

What this trial tests

NA trial testing G-Premio Bond in etch&rinse mode in Healthy Participant in 47 participants. Status unknown.

Timeline

1 September 2018

Primary endpoint
1 March 2021

1 January 2025

Quick facts

Lead sponsor	Hacettepe University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	47
Start date	1 September 2018
Primary completion	1 March 2021
Estimated completion	1 January 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

G-Premio Bond in etch&rinse mode
G-Premio Bond in selective-etch mode
G-Premio Bond in self-etch mode

Conditions studied

Healthy Participant — all drugs for Healthy Participant →

Sponsor

Hacettepe University

Who can join

Adults 18 to 75, any sex, with Healthy Participant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study was to evaluate the influence of smoking on the clinical performance of a universal adhesive used with different application modes in non-carious cervical lesions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy Participant

Currently open trials in the same condition.

NCT07455240 — A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults · Phase 1 · active not recruiting
NCT07153159 — A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding · Phase 1 · recruiting

Other Hacettepe University trials

Trials by the same sponsor.

NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04807465 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
Last refreshed: 23 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04807465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing